Full Text View
Tabular View
No Study Results Posted
Related Studies
Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
This study has been withdrawn prior to enrollment.
( Research never begun. )
Study NCT00361933   Information provided by University of Washington

First Received on August 8, 2006.   Last Updated on June 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Giant Lymph Node Hyperplasia
Additional conditions recognized in this trial
Hyperplasia
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Pathologic Processes
Interventions listed in this trial
Valganciclovir
Additional drug interventions recognized in this trial
Ganciclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Washington
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services